Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway

OBJECTIVE: To study the effects of different disease-modifying antirheumatic drugs (DMARD) on different events mediated by IL-15-activated lymphocytes. METHODS: Peripheral blood lymphocytes (PBL) were isolated from healthy donors and activated with IL-15 after exposure to different DMARD: leflunomid...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Alvaro, I, Ortiz, A M, Domínguez-Jiménez, C, Aragón-Bodi, A, Sánchez, B Díaz, Sánchez-Madrid, F
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2008
Materias:
Basic and Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946060/
https://www.ncbi.nlm.nih.gov/pubmed/18957484
http://dx.doi.org/10.1136/ard.2008.096743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946060/
https://www.ncbi.nlm.nih.gov/pubmed/18957484
http://dx.doi.org/10.1136/ard.2008.096743

Ejemplares similares